Corporate Banner
Satellite Banner
Technology Networks Header
Monday, September 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Cancer-Fighting Drugs Might Also Stop Malaria Early
A number of compounds have been identified which could be used to fight malaria.
Collaboration Leads to Possible Shortcut to New Drugs
The reaction, reported in Science, demonstrates how a carboxylic acid can be transformed into a very reactive site through use of a novel photoredox catalyst.
Catalysts That Mimic Enzymes Could Revolutionize Pharmaceutical Manufacturing
Structures made of polymer chains allow the catalysts to work in water.
Discovery of How Taxol Works Could Lead to Better Anticancer Drugs
The drug’s interference with the normal function of microtubules could help in designing better anticancer drugs.
Chemists Discover Cancer Drug Candidate Structure
Chemists at The Scripps Research Institute have determined the correct structure of a highly promising anticancer compound approved by the U.S. FDA for clinical trials in cancer patients.
Novel Drug Targets for Allergy Identified
Researchers have identified several target molecules which are suitable for the development of new allergy drugs.
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells
New drug prevents tumour growth by inhibiting the nucleotide sanitizing enzyme MTH1.
New Trial of Personalized Cancer Treatment Begins in Oxford
Phase I trial in Oxford will investigate a new drug, called CXD101.
Flow Microreactor Synthesis in Organo-Fluorine Chemistry
This review focuses on successful examples on synthesis and reactions of fluorine-containing molecules by the use of flow microreactor systems.

Molecular Dynamics Study of Amyloid Formation of Two Abl-SH3 Domain Peptides: Single and Multiple Beta-sheets
Inta Liepina, Principal Scientist, Latvian Institute of Organic Synthesis, speaking at virtual Discovery 2008

Novel Recombinant Peptide Toxin Fusion Proteins as Potential Therapeutics for the Treatment of Autoimmune Disease
Hung Nguyen, Principal Scientist, Amgen, speaking at Ion Channel Targets 2008

Chemogenomics: Medicinal Chemistry Meets Pharmacology at a Genome Scale
Jordi Mestres, Head Chemogenomics Lab, Universitat Pompeu Fabra, speaking at Screening Europe 2009

Chemogenomics in Drug Discovery
Hugo Kubinyi, Retired Professor, Pharmaceutical Chemistry, University of Heidelberg, speaking at MedChem Europe 2009

SOSA and Parallel in silico Screening: Merging Medicinal Chemistry Tradition with a Modern Computational Approach
Thierry Langer, CEO, Prestwick Chemicals, speaking at MedChem Europe 2009

Prediction of Drug-Drug Interactions Caused by Metabolism-Based Inhibition of Cytochrome P450 Using a Mechanistic Static Model: The Weak & Missing Links?
Olivier Barberan, Director of Product Development, AUREUS-Pharma, speaking at ADMET Europe 2009

Ion Channel Panels for Safety Assessment and Drug Discovery
Arthur "Buzz" Brown, President & CEO, ChanTest Corporation, speaking at Ion Channel Targets 2008

Chemical Activation of Voltage-Gated Potassium Channels
Min Li, Professor, Department of Neuroscience & High Throughput Biology Center, Johns Hopkins School of Medicine, speaking at Ion Channel Targets 2008

Principles for 3D/4D Classification of Drugs
Vladimir Potemkin, Head of Organic Chemistry Department, Chelyabinsk State University, speaking at Virtual Discovery 2008

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 128
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv